Realcan Pharmaceutical Group (002589.SZ) announced on June 24 that as of June 21, 2024, Yantai Huitou Investment Development Partnership Enterprise (Limited Partnership) (referred to as "Yantai Huitou") established by the company's directors, supervisors, and management team, accumulated 2.6386 million shares of the company through the Shenzhen Stock Exchange system by centralized bidding, accounting for 0.1754% of the company's total equity, and the total amount of shareholding reached CNY 6,006,717. The shareholding plan for this time has been implemented.
瑞康医药(002589.SZ)：董事、监事及高管团队完成增持263.86万股
Realcan Pharmaceutical Group (002589.SZ): Directors, supervisors and executives have completed a shareholding of 2.6386 million shares.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.